Canagliflozin, a sodium glucose co-transporter 2 (SGLT2) inhibitor, has been developed for the treatment of adults with type 2 diabetes mellitus (T2DM). During the phase 3 program, treatment-related pheochromocytomas, renal tubular tumors, and testicular Leydig cell tumors were reported in the 2-year rat toxicology study. Treatment-related tumors were not seen in the 2-year mouse study. A cross-functional, mechanism-based approach was undertaken to determine whether the mechanisms responsible for tumorigenesis in the rat were of relevance to humans. Based on findings from nonclinical and clinical studies, the treatment-related tumors observed in rats were not deemed to be of clinical relevance. Here, we describe the scientific and regulatory journey from learning of the 2-year rat study findings to the approval of canagliflozin for the treatment of T2DM.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1177/0192623314557179 | DOI Listing |
J Mood Anxiety Disord
December 2024
Harvard University, 52 Oxford Street, Cambridge, MA 02138, United States.
Background: Recurrent symptom-relevant negative autobiographical memories are common in patients with emotional disorders such as anxiety and depression, even among those without a trauma-related diagnosis. Recurrent negative autobiographical memories may also contribute to distress in non-clinical populations.
Methods: To examine the prevalence of recurrent negative autobiographical memories and associated psychological features, we recruited a student sample ( = 101) and a treatment-seeking sample of patients with emotional disorders ( = 123).
Cureus
December 2024
Clinical Laboratory Sciences, Jouf University, Jouf, SAU.
Background: With increasing reliance on digital devices, concerns about their impact on mental health have grown, particularly among young adults.
Aim: This study aims to evaluate the impact of a digital detox intervention on reducing anxiety and depression among young adults across diverse demographic backgrounds.
Methods: A pre-test, followed by a digital detox intervention, and a post-test using an online survey was carried out.
Toxicol Res
January 2025
Gyeongsang National University, 501 Jinju-Daero, Jinju-Si, Gyeongnam-Do 52828 Republic of Korea.
Bacterial vaginosis (BV) is a microbial dysbiosis that shifts the paradigms of vaginal flora from lactobacilli to opportunistic pathogens. Globally, BV is treated with antibiotic therapy and recurrence rates are > 70% occurring within 6 months due to antibiotic resistance against pathogenic bacteria. An incorporation of orally or intravaginally for the recolonization of healthy microbes in vagina is the suggested course of treatment.
View Article and Find Full Text PDFBJPsych Open
January 2025
Department of Psychiatry, Faculty of Medicine, University of Southampton, Southampton, UK.
Background: Alcohol use in autism spectrum disorder (ASD) is under-researched. Previous reviews have explored substance use as a whole, but this neglects individual characteristics unique to different substances. Alcohol use in non-clinical samples is associated with diverse responses.
View Article and Find Full Text PDFBMJ Open Qual
December 2024
Conversaurus, Richmond, UK.
Communication is fundamental to effective healthcare. Misunderstandings can increase distress, risks and costs. Clean Language is a precision questioning technique-with specific Clean Language questions which minimise assumptions and bias.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!